ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

Published Date: 29 May 2025

For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compared with dipeptidyl peptidase-4 (DPP-4) inhibitors, according ...

Read Full News

Latest News

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Ureteroscopy and histopathology should be considered as routine preoperative assessments

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Not surprisingly, trust in government health agencies for cancer info has dipped

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

News, features, and commentary about cancer-related issues

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Diagnosis complicated by absence of radiologic evidence of hepatic lesions

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Terminology also makes a difference

Latest News

Targeted therapy in 3 boys allowed for conservative surgery to restore jaw to predisease state

Ureteroscopy and histopathology should be considered as routine preoperative assessments

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Not surprisingly, trust in government health agencies for cancer info has dipped

Response rates with daraxonrasib ranged from 31% to 37% in previously treated RAS-mutant NSCLC

News, features, and commentary about cancer-related issues

News All Time

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

All responding NCCN members reported shortages, priorities identified but solutions still needed

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Early efficacy among the highest seen in lung cancer, expert says

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Bispecific antibody and ADC together impress in early study

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

If approved, immunotherapy gotistobart could offer a chemo-free option in second-line setting

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Practice-changing median of 14.3 months with T-DXd, but caution over early unfavorable OS trend

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Case highlights need for quick diagnosis and management of rare disorder

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

News, features, and commentary about cancer-related issues

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

— Comments were noncommittal in agency document released ahead of advisors' meeting

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Definium Therapeutics said on Monday its LSD-based treatment reduced symptoms of generalized anxiety disorder ⁠in a second successful late-stage study for the...

Liberalized Cannabis Policies May Increase Substance Use

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

UK Lawmakers Reject Bid to Legalise Assisted Dying

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

‘Modest’ Differences in OAT Should Not Obscure Benefits

Methadone may be linked to a lower risk for death than buprenorphine-naloxone in the short term, but after an overdose, either opioid agonist therapy is better than none.

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

(This Aug 27 story has been republished, with no changes to text.)

Less Seniors Taking Inappropriate Cognitive Meds

Older adults with cognitive disorders who use inappropriate medications linked to adverse cognitive effects are more likely to have poor mental health-related quality of life.

Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment

Annual whole-body, low-dose CT aids management of smoldering multiple myeloma

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

"Unusual" Cancers Following Pandemic; Triumph in TNBC; Clinical Trial Interrupted by Shortage.

3.

ACS Guidelines Expand Lung Cancer Screening Eligibility -- Is That a Good Thing?

4.

3D virtual staining technology enables non-invasive observation of cancer tissue

5.

ASCO Future Focus: Follicular Lymphoma: Future Focus from the American Society of Clinical Onology

1.

Strategic Applications in Hematology in Clinical Decision-Making

2.

Medical Education Through Morphology-Based Learning of Hematopoietic Disorders

3.

Progressive Insights in Hematology in the Digital Era

4.

Navigating the Complexities of Esophageal Cancer Staging

5.

Uncovering the Mystery of the Sessile Serrated Adenoma

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Understanding the Importance of Early Cancer Detection

2.

Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

ASCO: GLP-1 receptor agonists may reduce risk for obesity-related cancer, all-cause death

Latest News

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

Transforming Perioperative MIBC Care in Community Practice: Navigating Emerging Data, Guideline Changes, and Adverse Event Management Protocols

Doctors Remain Trusted Sources for Cancer Info in Post-Pandemic Era

Groundbreaking Pancreatic Cancer Drug Shows Promise in Lung Cancer

Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Todays Updates

Optimizing Care Transitions and Referral Decision-Making Across the HNSCC Continuum

Liver Failure or Liver Mets?

Here's Why Hematuria in a Young Patient Should Always Be Investigated

Latest News

News All Time

Cancer Drug Shortages Continue With No Immediate Path Toward Relief

ROS1-Targeting Lung Cancer Drug Yields 90% Response Rate

Drug Combo's Response Rates Top 90% in Small Cell Lung Cancer Trial

Novel Drug Cuts Risk for Death by 44% in Squamous Lung Cancer Trial

Unprecedented PFS in HER2-Mutant Lung Cancer, but With a Touch of Controversy

Woman Develops Tiny Blood Spots on Her Body After COVID Shot

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Patient's Colonoscopy Refusal Highlights Value of CRC Screening

RFK Jr. Eyes Wireless, RF Radiation; Cancer by the Month; AI for Cancer Symptoms

FDA Staff Find No Major Concerns With Galleri Multicancer Early Detection Test

Definium's LSD-based Anxiety, Depression Drug Scores Another Trial Win

Liberalized Cannabis Policies May Increase Substance Use

UK Lawmakers Reject Bid to Legalise Assisted Dying

‘Modest’ Differences in OAT Should Not Obscure Benefits

EU Flags Shortage Of Schizophrenia Drug Injections Due to Manufacturing Issues

Less Seniors Taking Inappropriate Cognitive Meds

Recommended News For You

Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.

Real-World Liso-Cel Results in MCL Consistent With Trials